JP2012092108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012092108A5 JP2012092108A5 JP2011252115A JP2011252115A JP2012092108A5 JP 2012092108 A5 JP2012092108 A5 JP 2012092108A5 JP 2011252115 A JP2011252115 A JP 2011252115A JP 2011252115 A JP2011252115 A JP 2011252115A JP 2012092108 A5 JP2012092108 A5 JP 2012092108A5
- Authority
- JP
- Japan
- Prior art keywords
- increased
- composition
- peptide
- group
- bioactive component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 6
- 229960003604 testosterone Drugs 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 230000000975 bioactive effect Effects 0.000 claims 4
- 239000006286 aqueous extract Substances 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 238000004007 reversed phase HPLC Methods 0.000 claims 3
- 230000019100 sperm motility Effects 0.000 claims 3
- 238000003786 synthesis reaction Methods 0.000 claims 3
- 240000005739 Eurycoma longifolia Species 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 239000012501 chromatography medium Substances 0.000 claims 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 1
- 108010015899 Glycopeptides Proteins 0.000 claims 1
- 102000002068 Glycopeptides Human genes 0.000 claims 1
- 238000011993 High Performance Size Exclusion Chromatography Methods 0.000 claims 1
- 208000007466 Male Infertility Diseases 0.000 claims 1
- 206010057672 Male sexual dysfunction Diseases 0.000 claims 1
- 238000013375 chromatographic separation Methods 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000005194 fractionation Methods 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000001542 size-exclusion chromatography Methods 0.000 claims 1
- 210000001550 testis Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI20003988 | 2000-08-29 | ||
| MYPI20003988A MY134867A (en) | 2000-08-29 | 2000-08-29 | Bioactive fraction of eurycoma longifolia |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002522919A Division JP2004521075A (ja) | 2000-08-29 | 2001-02-14 | ユウリコマロンギフォリアの生理活性フラクション |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012092108A JP2012092108A (ja) | 2012-05-17 |
| JP2012092108A5 true JP2012092108A5 (enExample) | 2013-05-02 |
| JP5607013B2 JP5607013B2 (ja) | 2014-10-15 |
Family
ID=19749476
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002522919A Pending JP2004521075A (ja) | 2000-08-29 | 2001-02-14 | ユウリコマロンギフォリアの生理活性フラクション |
| JP2011252115A Expired - Lifetime JP5607013B2 (ja) | 2000-08-29 | 2011-11-17 | ユウリコマロンギフォリアの生理活性フラクション |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002522919A Pending JP2004521075A (ja) | 2000-08-29 | 2001-02-14 | ユウリコマロンギフォリアの生理活性フラクション |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1313491B1 (enExample) |
| JP (2) | JP2004521075A (enExample) |
| AU (1) | AU2001247966A1 (enExample) |
| DE (1) | DE60125955T2 (enExample) |
| DK (1) | DK1313491T3 (enExample) |
| MY (1) | MY134867A (enExample) |
| WO (1) | WO2002017946A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004075901A2 (en) * | 2003-02-25 | 2004-09-10 | Mesko Charles A | Compositon for increasing levels of hormones and a method for preparation of said composition |
| MY146000A (en) * | 2006-08-07 | 2012-06-15 | Univ Sains Malaysia | Polar organic extract of eurycoma longifolia |
| KR100969325B1 (ko) * | 2010-02-08 | 2010-07-09 | 인천대학교 산학협력단 | 홍조류로부터 비독성 자외선 차단용 추출물을 제조하는 방법 및 이를 이용한 비독성 자외선 차단제 |
| CN102948569A (zh) * | 2011-08-18 | 2013-03-06 | 顾立峰 | 东革阿里提取物及其应用 |
| KR101413643B1 (ko) * | 2012-12-12 | 2014-07-04 | (주) 닥터코스텍 | 유리코마 롱기폴리아 추출물을 함유하는 화장료 및 이의 제조 방법 |
| WO2014148883A1 (en) * | 2013-03-20 | 2014-09-25 | Natureceuticals Sdn Bhd | Herbaceutical formulations |
| JP6683897B1 (ja) * | 2018-08-21 | 2020-04-22 | 日本たばこ産業株式会社 | 深部体温低下剤 |
| US11058737B2 (en) | 2018-10-29 | 2021-07-13 | Biotropics Malaysia Berhad | Use of Euycoma longifolia extract in alleviating symptoms and/or conditions associated with hormonal imbalance in females |
| CN109456418B (zh) * | 2019-01-17 | 2020-10-27 | 齐齐哈尔大学 | 一种活性东革阿里多糖及制备方法 |
-
2000
- 2000-08-29 MY MYPI20003988A patent/MY134867A/en unknown
-
2001
- 2001-02-14 EP EP01920972A patent/EP1313491B1/en not_active Expired - Lifetime
- 2001-02-14 DK DK01920972T patent/DK1313491T3/da active
- 2001-02-14 AU AU2001247966A patent/AU2001247966A1/en not_active Abandoned
- 2001-02-14 DE DE60125955T patent/DE60125955T2/de not_active Expired - Lifetime
- 2001-02-14 WO PCT/US2001/040101 patent/WO2002017946A1/en not_active Ceased
- 2001-02-14 JP JP2002522919A patent/JP2004521075A/ja active Pending
-
2011
- 2011-11-17 JP JP2011252115A patent/JP5607013B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ759512A (en) | Delayed release compositions of linaclotide | |
| HRP20171175T1 (hr) | Novi triciklički spojevi | |
| EP2121546A4 (en) | PROCESS FOR THE PREPARATION OF ALPHA, OMEGA-DICARBOXYLIC ACID DERIVATIVES BY METATHESIS | |
| JP2011168603A5 (enExample) | ||
| WO2015040640A3 (en) | An improved process for the preparation of tenofovir alafenamide or pharmaceutically acceptable salts thereof | |
| RU2015146614A (ru) | Конъюгированная вакцина на основе пептида антигена wt1 | |
| MX393384B (es) | Adyuvantes sinteticos de glucopiranosil-lipido. | |
| WO2015024668A3 (en) | Respiratory syncytial virus (rsv) vaccine | |
| HRP20190982T1 (hr) | Peptidi i njihova uporaba | |
| FR2962437B1 (fr) | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique | |
| HK1198359A1 (en) | Carrier-linked treprostinil prodrugs | |
| NZ602111A (en) | Extended release formulations of rasagiline and uses thereof | |
| JP2008533007A5 (enExample) | ||
| IL209967A (en) | Peptides capable of inducing cytotoxic lymphocyte (ctl), medicinal preparations containing them and their use and in vitro methods of inducing ctl | |
| MX348393B (es) | Polimorfo de rifaximina y proceso para la preparacion del mismo. | |
| WO2013082535A3 (en) | Controlled-release peptide compositions and uses thereof | |
| JP2014533681A5 (enExample) | ||
| EP2762153A3 (en) | Vaccine composition for mucosal administration | |
| UA112764C2 (uk) | Оптимізований синтез чистих, неполіморфних кристалічних жовчних кислот із заданим розміром частинок | |
| WO2008104852A3 (en) | Pharmaceutical compositions comprising adsorbate of fenofibrate | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| PT2722322T (pt) | Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral | |
| WO2011121607A3 (en) | Rasagiline and its pharmaceutically acceptable salts | |
| WO2012164575A3 (en) | Amorphous ritonavir co-precipitated | |
| EP2364967A3 (en) | Process for preparation of rasagiline and salts thereof |